Lineage Cell Therapeutics Inc (LCTX)
1.055
+0.04
(+4.46%)
USD |
NYAM |
May 22, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics 1 Year Total Returns (Daily): -25.19% for May 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 21, 2024 | -25.19% |
May 20, 2024 | -22.96% |
May 17, 2024 | -21.74% |
May 16, 2024 | -22.06% |
May 15, 2024 | -21.58% |
May 14, 2024 | -24.64% |
May 13, 2024 | -21.01% |
May 10, 2024 | -18.18% |
May 09, 2024 | -19.73% |
May 08, 2024 | -22.15% |
May 07, 2024 | -11.89% |
May 06, 2024 | -9.09% |
May 03, 2024 | -27.40% |
May 02, 2024 | -22.79% |
May 01, 2024 | -13.74% |
April 30, 2024 | -19.85% |
April 29, 2024 | -17.65% |
April 26, 2024 | -15.56% |
April 25, 2024 | -15.91% |
April 24, 2024 | -20.29% |
April 23, 2024 | -14.93% |
April 22, 2024 | -14.93% |
April 19, 2024 | -16.06% |
April 18, 2024 | -13.67% |
April 17, 2024 | -5.84% |
Date | Value |
---|---|
April 16, 2024 | -18.44% |
April 15, 2024 | -11.35% |
April 12, 2024 | -7.14% |
April 11, 2024 | 1.44% |
April 10, 2024 | -3.57% |
April 09, 2024 | 2.19% |
April 08, 2024 | 7.30% |
April 05, 2024 | 1.45% |
April 04, 2024 | -1.37% |
April 03, 2024 | -10.53% |
April 02, 2024 | -6.67% |
April 01, 2024 | -2.67% |
March 28, 2024 | 8.03% |
March 27, 2024 | 0.72% |
March 26, 2024 | -10.27% |
March 25, 2024 | -12.33% |
March 22, 2024 | -7.30% |
March 21, 2024 | -2.16% |
March 20, 2024 | -11.59% |
March 19, 2024 | -14.18% |
March 18, 2024 | -17.02% |
March 15, 2024 | -4.44% |
March 14, 2024 | -16.55% |
March 13, 2024 | -14.79% |
March 12, 2024 | -13.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.20%
Minimum
Sep 04 2019
294.9%
Maximum
Mar 18 2021
14.72%
Average
-13.54%
Median
1 Year Total Returns (Daily) Benchmarks
Acumen Pharmaceuticals Inc | -36.07% |
Sarepta Therapeutics Inc | -13.40% |
CEL-SCI Corp | -48.83% |
AIM ImmunoTech Inc | -13.52% |
IGC Pharma Inc | 60.28% |